[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"observational\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:observational":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100305234",false,"NCT03253536","Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma","LIVERCARE","Inclusion Criteria:\n\n* histologically or radiologically proven hepatocellular carcinoma\n* 1-3 lesions suitable for stereotactic radiation therapy\n* indication for SBRT according to multidisciplinary board evaluation\n* age \\>= 18 years\n* written informed consent for study participation\n* mental and verbal ability to complete standardized questionaires according to assessment by investigator (physician)\n\nExclusion Criteria:\n\n* age \\\u003C 18 years\n* prior HCC specific systemic therapy\n* concurrent oncological systemic treatment\n* distant metastases\n* inadequate ability tobe compliant with the protocol or to complete standardizes questionaires\n* inability to receive contrast-enhanced planning CT\n* missing ability to give informed consent\n* legal custody","ALL","18 Years",{"count":18,"type":19},100,"ESTIMATED","OBSERVATIONAL","Prospective single arm, single center observational study to evaluate Quality of Life (Qol) after stereotactic body radiotherapy for patients with hepatocellular cancer. Patients will receive work-up, treatment and follow-up exclusively as routinely done except additional quality of life measurements. Qol will be measured by standardized and validated EORTC questionaires at different time points during routine follow-up.",[23,24,25,26],"Hepatocellular Cancer","Quality of Life","Stereotactic Body Radiation Therapy","Observational",[23,24,28,29],"stereotactic body radiation therapy","observational","RECRUITING","2017-08-16",{"date":33,"type":34},"2017-08-18","ACTUAL",{"date":36,"type":34},"2017-07-10",{"date":38,"type":19},"2027-07-10",{"name":40,"class":41},"Ludwig-Maximilians - University of Munich","OTHER",""]